Cronos Group Inc. CRON, 2.00%CRON, 2.19% said Monday it has purchased an option to acquire a 10.5% stake in U.S. cannabis company PharmaCann in a deal valued at $110.4 million.
Read Full Article Here
Credit to: MarketWatch – By Ciara Linnane
Canadian cannabis company Cronos purchases option to acquire 10.5% stake in PharmaCann for $110.4 million
- by MjpCapital